CRINETICS PHARMACEUTICALS IN's ticker is CRNX and the CUSIP is 22663K107. A total of 95 filers reported holding CRINETICS PHARMACEUTICALS IN in Q3 2021. The put-call ratio across all filers is - and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2021 | $32,000 | +14.3% | 1,500 | 0.0% | 0.00% | 0.0% |
| Q2 2021 | $28,000 | +21.7% | 1,500 | 0.0% | 0.00% | +33.3% |
| Q1 2021 | $23,000 | +9.5% | 1,500 | 0.0% | 0.00% | 0.0% |
| Q4 2020 | $21,000 | -55.3% | 1,500 | -50.0% | 0.00% | -62.5% |
| Q3 2020 | $47,000 | -11.3% | 3,000 | 0.0% | 0.01% | -20.0% |
| Q2 2020 | $53,000 | +20.5% | 3,000 | 0.0% | 0.01% | +11.1% |
| Q1 2020 | $44,000 | -41.3% | 3,000 | 0.0% | 0.01% | -35.7% |
| Q4 2019 | $75,000 | +66.7% | 3,000 | 0.0% | 0.01% | +55.6% |
| Q3 2019 | $45,000 | -40.0% | 3,000 | 0.0% | 0.01% | -40.0% |
| Q2 2019 | $75,000 | – | 3,000 | – | 0.02% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Vivo Capital, LLC | 3,375,169 | $76,819,000 | 7.66% |
| RA Capital Management | 1,875,209 | $42,680,000 | 1.84% |
| Perceptive Advisors | 2,587,953 | $58,901,000 | 1.66% |
| EMORY UNIVERSITY | 97,035 | $2,209,000 | 1.55% |
| New Leaf Venture Partners, L.L.C. | 167,700 | $3,817,000 | 1.05% |
| Orbimed Advisors | 1,914,282 | $43,569,000 | 0.67% |
| Opaleye Management Inc. | 73,000 | $1,661,000 | 0.46% |
| Novo Holdings A/S | 135,009 | $3,073,000 | 0.46% |
| Virtus ETF Advisers LLC | 7,934 | $181,000 | 0.38% |
| Eventide Asset Management | 384,000 | $8,740,000 | 0.30% |